Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1995 May;4(7):S21–S25. doi: 10.1155/S0962935195000809

Topical levocabastine—a review of therapeutic efficacy compared with topical sodium cromoglycate and oral terfenadine on days with high pollen counts

Marianela de Azevedo 1
PMCID: PMC2365680  PMID: 18475685

Abstract

Levocabastine is a new H1-receptor antagonist specifically developed for the topical treatment of seasonal allergic rhinoconjunctivitis. Clinical experience to date clearly demonstrates that levocabastine eye drops and nasal spray are effective and well tolerated for the treatment of this allergic disorder. Analysis of data from a number of comparative trials reveals that topical levocabastine is at least as effective as sodium cromoglycate and the oral antihistamine terfenadine, even on days with high pollen counts (≥ 50 pollen particles/m3 ) when symptoms are severe. Coupled with a rapid onset of action and twice daily dosing, these findings make topical levocabastine an attractive alternative to other therapeutic approaches as a first-line therapy for the treatment, of this common condition.

Full Text

The Full Text of this article is available as a PDF (517.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azevedo M., Castel-Branco M. G., Oliveira J. F., Ramos E., Delgado L., Almeida J. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis. Clin Exp Allergy. 1991 Nov;21(6):689–694. doi: 10.1111/j.1365-2222.1991.tb03197.x. [DOI] [PubMed] [Google Scholar]
  2. Bahmer F. A., Ruprecht K. W. Safety and efficacy of topical levocabastine compared with oral terfenadine. Ann Allergy. 1994 May;72(5):429–434. [PubMed] [Google Scholar]
  3. Davies B. H., Mullins J. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis. Allergy. 1993 Oct;48(7):519–524. doi: 10.1111/j.1398-9995.1993.tb01108.x. [DOI] [PubMed] [Google Scholar]
  4. Dechant K. L., Goa K. L. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs. 1991 Feb;41(2):202–224. doi: 10.2165/00003495-199141020-00006. [DOI] [PubMed] [Google Scholar]
  5. Frostad A. B., Olsen A. K. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis. Clin Exp Allergy. 1993 May;23(5):406–409. doi: 10.1111/j.1365-2222.1993.tb00346.x. [DOI] [PubMed] [Google Scholar]
  6. Knight A. The role of levocabastine in the treatment of allergic rhinoconjunctivitis. Br J Clin Pract. 1994 May-Jun;48(3):139–143. [PubMed] [Google Scholar]
  7. Palma-Carlos A. G., Chieira C., Conde T. A., Cordeiro J. A. Double-blind comparison of levocabastine nasal spray with sodium cromoglycate nasal spray in the treatment of seasonal allergic rhinitis. Ann Allergy. 1991 Oct;67(4):394–398. [PubMed] [Google Scholar]
  8. Palma-Carlos A. G., Palma-Carlos M. L., Rombaut N. The effect of levocabastine nasal spray in nasal provocation tests. Int J Clin Pharmacol Res. 1988;8(1):25–30. [PubMed] [Google Scholar]
  9. Stokes T. C., Feinberg G. Rapid onset of action of levocabastine eye-drops in histamine-induced conjunctivitis. Clin Exp Allergy. 1993 Sep;23(9):791–794. doi: 10.1111/j.1365-2222.1993.tb00368.x. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES